DCP Capital, a private equity firm established by KKR’s former heads of China in 2019, is set to acquire Vitaco Health Group, the owner of sports nutrition, body-building protein powders and supplements brands.
Vitaco’s Chinese owners, Primavera Capital and Shanghai Pharmaceuticals, are in advanced negotiations to sell the business to DCP for around $450 million. Barclays and Barrenjoey Capital Partners are advising the vendors, while Lazard is in DCP’s corner.
Loading...
Sarah Thompson has co-edited Street Talk since 2009, specialising in private equity, investment banking, M&A and equity capital markets stories. Prior to that, she spent 10 years in London as a markets and M&A reporter at Bloomberg and Dow Jones. Email Sarah at sarah.thompson@afr.com
Emma Rapaport is a co-editor of the Street Talk column. Prior to that, she was a markets reporter at The Australian Financial Review. Connect with Emma on Twitter. Email Emma at emma.rapaport@afr.com